Black, Hispanic patients underrepresented in cancer trials, raises concern about drug efficacy

Between 2008 and 2018, fewer than 8 percent of cancer trials in the United States had participation from white, Asian-American, black and Hispanic patients all at once.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news